PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules
VANCOUVER, BC — PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA)(OTCQB:PMBHF), a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo™ MDMA and novel MDXX compounds, and Filament Health Corp…. Read More




